Molecular basis for the generation in pigs of influenza A viruses with pandemic potential | Journal of Virology | 1998 | 752 |
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes | Journal of Immunology | 1994 | 574 |
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor | Cell | 1992 | 469 |
Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways | Nature | 1990 | 275 |
Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis | Proceedings of the National Academy of Sciences of the United States of America | 1989 | 267 |
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes | Proceedings of the National Academy of Sciences of the United States of America | 1994 | 249 |
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays | Molecular Immunology | 1994 | 214 |
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant | Science | 1992 | 201 |
On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs | Journal of Immunology | 1991 | 194 |
Antigen analogs/MHC complexes as specific T cell receptor antagonists | Annual Review of Immunology | 1994 | 182 |
Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II | Journal of Experimental Medicine | 1995 | 165 |
Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype | Journal of Immunology | 1995 | 149 |
Functional consequences of engagement of the T cell receptor by low affinity ligands | Journal of Immunology | 1993 | 147 |
T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus | Journal of Experimental Medicine | 1995 | 140 |
MHC interaction and T cell recognition of carbohydrates and glycopeptides | Journal of Immunology | 1992 | 135 |
Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition | Journal of Immunology | 1991 | 123 |
T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis | European Journal of Immunology | 1994 | 115 |
Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme | Nature | 1989 | 114 |
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study | Lancet Oncology, The | 2015 | 113 |
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI) | Vaccine | 2011 | 106 |
HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions | Journal of Immunology | 1993 | 103 |
Characterization of the specificity of peptide binding to four DR haplotypes | Journal of Immunology | 1990 | 101 |
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults | Vaccine | 2010 | 100 |
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response | Vaccine | 2012 | 95 |
Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules | Journal of Immunology | 1990 | 95 |